sodium channel blockers (Neurosciences Victoria/Howard Florey Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namesodium channel blockers (Neurosciences Victoria/Howard Florey Institute)
Drug Alias Nameantioxidant agent (Neurosciences Victoria/Howard Florey Institute)HFI-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoward Florey Institute of Experimental Physiology and Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoward Florey Institute of Experimental Physiology and MedicineNeurosciences Victoria Ltd
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A